World Tuberculosis Day: ERA4TB accelerating the development of new treatment regimens

ERA4TB (the European Regimen Accelerator for Tuberculosis) is a 6-year public-private partnership with a total budget of over €200M that began in 2020 with the goal of accelerating the development of new treatment regimens for tuberculosis (TB). As part of the Innovative Medicines Initiative, ERA4TB brings together experts from academia and pharma, led by Stewart Cole (Institut Pasteur) and David Barros-Aguirre (GlaxoSmithKline). The project coordinator is Juan José Vaquero (University Carlos III Madrid) and three members of the Institut Pasteur International Network are among the 30 ERA4TB partners: the Institut Pasteur (Paris), the Institut Pasteur de Lille and Sciensano (Brussels). On March 24, World Tuberculosis Day, Stewart Cole says that TB control has been severely impacted by COVID-19 but ERA4TB will help make a difference.

Find out more